Penumbra Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
34.38 M |
Public Float |
26.12 M |
Penumbra Inc. | |
Stock Exchange | New York Stock Exchange |
EPS |
$0.3 |
Market Cap |
$5.65 B |
Shares Outstanding |
34.74 M |
Public Float |
31.16 M |
Address |
One Penumbra Place Alameda California 94502 United States |
Employees | - |
Website | http://www.penumbrainc.com |
Updated | 07/08/2019 |
Penumbra, Inc. engages in the design, development, manufacture, and marketing of innovative medical devices. It focuses on developing products for use by the specialist physicians, including interventional neuroradiologists, neurosurgeons, interventional neurologists, interventional radiologists, and vascular surgeons. Its products are designed to address ischemic stroke, hemorrhagic stroke and various peripheral vascular conditions that can be treated through thrombectomy and embolization procedures. |